Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394602 · ClinicalTrials.gov registry record
Chemoradiation-Induced Nausea and Emesis: Quality of Life
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 207
- Enrollment target
NCT00394602: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00394602 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394602 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 207 participants
- Enrollment target
Study Summary
The primary objectives of this study are: 1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation. 1. To compare preferences of cancer patients to those of healthy individuals. 2. To compare how patients' preferences for side-effects of chemoradiation change over time. 2. To longitudinally assess the quality of life of cancer patients scheduled to receive chemoradiation. 3. To determine the impact of nausea and vomiting associated with chemoradiation on patients' quality of life and evaluate potential change throughout the duration of chemoradiation treatment.
Interventions
- OTHER Questionnaire
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2004-04-07 |
| Est. Completion | 2019-05-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394602
The ClinicalTrials.gov registry entry for NCT00394602 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00394602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394602 about?
NCT00394602 is a clinical study titled "Chemoradiation-Induced Nausea and Emesis: Quality of Life". The primary objectives of this study are: 1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation. 1. To compare preferences of cancer patients to those of healthy individuals. 2. To compare how patients' p...
What is the current status of trial NCT00394602?
This trial is currently terminated. The enrollment target is 207 participants. The study started on 2004-04-07. Estimated completion is 2019-05-08.
What interventions are being tested in trial NCT00394602?
The interventions under investigation include: Questionnaire (OTHER), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00394602?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.